Increased levels of nitric oxide metabolites in urine from leprosy patients in reversal reaction.

We measured the metabolites of NO [nitrite (NO2-) and nitrate (NO3-)] in urine from Ethiopian patients suffering from leprosy. The urinary level of NO2-/NO3- in a group of healthy Ethiopians was 1020 +/- 471 microM (n = 22). Leprosy patients in reversal reaction had significantly higher levels of NO2-/NO3- (1817 +/- 492 microM, p < 0.001, n = 12) than both the control group and leprosy patients who were not in reversal reaction (1079 +/- 446 microM, n = 12). We conclude that the reversal reaction in leprosy in associated with increased urinary levels of nitric oxide metabolites.

[1]  K. Fälth‐magnusson,et al.  Significantly increased levels of nitric oxide products in urine of children with celiac disease. , 1998, Journal of pediatric gastroenterology and nutrition.

[2]  A. Katz.  Leprosy (Hansen's Disease): Summary Notes , 1998, Journal of cutaneous medicine and surgery.

[3]  S. Khare,et al.  Release of reactive nitrogen intermediates from the peripheral blood-derived monocytes/macrophages of leprosy patients stimulated in vitro by tuftsin. , 1997, Leprosy review.

[4]  N. Anstey,et al.  Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression , 1996, The Journal of experimental medicine.

[5]  N. Boéchat,et al.  Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis , 1996, The Journal of experimental medicine.

[6]  F. Fang,et al.  NO inhibitions: antimicrobial properties of nitric oxide. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  K. Tanaka,et al.  Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis , 1995, Infection and immunity.

[8]  L. Ignarro,et al.  A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase. , 1993, Analytical biochemistry.

[9]  B. Bloom,et al.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.

[10]  C. Kablitz,et al.  Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. , 1992, The Journal of clinical investigation.

[11]  S. Franzblau,et al.  L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. , 1991, Journal of immunology.

[12]  C. Nathan,et al.  Nitric oxide and macrophage function. , 1997, Annual review of immunology.

[13]  E. Anggard.  Nitric oxide: mediator, murderer, and medicine. , 1994, Lancet.

[14]  D. Ridley,et al.  Classification of leprosy according to immunity. A five-group system. , 1966, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[15]  W. Rand,et al.  Nitrate biosynthesis in man ( metabolism / stable isotopes / carcinogenesis ) , 2022 .